High Glucose Increases Angiopoietin-2 Transcription in Microvascular Endothelial Cells through Methylglyoxal Modification of mSin3A*

Methylglyoxal is a highly reactive dicarbonyl degradation product formed from triose phosphates during glycolysis. Methylglyoxal forms stable adducts primarily with arginine residues of intracellular proteins. The biologic role of this covalent modification in regulating cell function is not known. Here we report that in mouse kidney endothelial cells, high glucose causes increased methylglyoxal modification of the corepressor mSin3A. Methylglyoxal modification of mSin3A results in increased recruitment of O-GlcNAc-transferase, with consequent increased modification of Sp3 by O-linked N-acetylglucosamine. This modification of Sp3 causes decreased binding to a glucose-responsive GC-box in the angiopoietin-2 (Ang-2) promoter, resulting in increased Ang-2 expression. Increased Ang-2 expression induced by high glucose increased expression of intracellular adhesion molecule 1 and vascular cell adhesion molecule 1 in cells and in kidneys from diabetic mice and sensitized microvascular endothelial cells to the proinflammatory effects of tumor necrosis factor α. This novel mechanism for regulating gene expression may play a role in the pathobiology of diabetic vascular disease.

[1]  J. Navarro,et al.  Renal Pro-Inflammatory Cytokine Gene Expression in Diabetic Nephropathy: Effect of Angiotensin-Converting Enzyme Inhibition and Pentoxifylline Administration , 2007, American Journal of Nephrology.

[2]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[3]  R. Atkins,et al.  Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. , 2005, Journal of the American Society of Nephrology : JASN.

[4]  T. Gardner,et al.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. , 2005, Diabetes.

[5]  M. Cooper,et al.  Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin–angiotensin system , 2005, Journal of hypertension.

[6]  Jiandie D. Lin,et al.  Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice , 2004, Cell.

[7]  A. Sapetschnig,et al.  Complexity of Translationally Controlled Transcription Factor Sp3 Isoform Expression* , 2004, Journal of Biological Chemistry.

[8]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Lin Li,et al.  Gene regulation by Sp1 and Sp3. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  I. Fingerman,et al.  p53-Mediated Transcriptional Activation From Test Tube to Cell , 2004, Cell.

[11]  H. Hammes,et al.  Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. , 2004, Diabetes.

[12]  Ashutosh Kumar Singh,et al.  Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix , 2004, Laboratory Investigation.

[13]  H. T. Kang,et al.  Down-regulation of Sp1 Activity through Modulation of O-Glycosylation by Treatment with a Low Glucose Mimetic, 2-Deoxyglucose* , 2003, Journal of Biological Chemistry.

[14]  Heike Brand,et al.  Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.

[15]  Paul J Thornalley.  Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation. , 2003, Biochemical Society transactions.

[16]  Paul J Thornalley,et al.  Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. , 2003, Biochemical Society transactions.

[17]  Paul J Thornalley,et al.  Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. , 2003, Biochemical Society transactions.

[18]  I. Fidler,et al.  Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. , 2003, Cancer research.

[19]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[20]  Xiaoyong Yang,et al.  Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A Coupling Protein O-GlcNAcylation to Transcriptional Repression , 2002, Cell.

[21]  A. Woolf,et al.  Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. , 2002, Kidney international.

[22]  J. Vandekerckhove,et al.  Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Brownlee.  Insight Review Articles , 2022 .

[24]  L. Ala‐Kokko,et al.  SP3 Represses the SP1-mediated Transactivation of the HumanCOL2A1 Gene in Primary and De-differentiated Chondrocytes* , 2001, The Journal of Biological Chemistry.

[25]  G. Nucifora,et al.  Genetic lesions and perturbation of chromatin architecture: A road to cell transformation , 2001, Journal of cellular biochemistry.

[26]  Xiaoyong Yang,et al.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Suske.  The Sp-family of transcription factors. , 1999, Gene.

[29]  F. Chaplen,et al.  Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. E. Kudlow,et al.  O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions , 1997, Molecular and cellular biology.

[31]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[32]  J P Richard,et al.  Mechanism for the formation of methylglyoxal from triosephosphates. , 1993, Biochemical Society transactions.

[33]  Paul J Thornalley,et al.  The formation of methylglyoxal from triose phosphates , 1993 .

[34]  J. Crabb,et al.  Establishment and characterization of a retinal Müller cell line. , 1998, Investigative ophthalmology & visual science.